ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr | ₹375 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹1,065 Cr |
Mar2024 | ₹486 Cr |
Mar2023 | ₹292 Cr |
Mar2022 | ₹378 Cr |
Mar2021 | ₹375 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,065 Cr | 119.13 | |
Mar2024 | ₹486 Cr | 66.59 | |
Mar2023 | ₹292 Cr | -22.87 | |
Mar2022 | ₹378 Cr | 0.77 | |
Mar2021 | ₹375 Cr | - |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹24,054.3 Cr | 0.7% | 8.7% | 72.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 0.7% |
8.7% |
72.4% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses